These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 20484206)

  • 61. The U.S. Food and Drug Administration responds to the International Academy of Compounding Pharmacists' outsourcing letter.
    Int J Pharm Compd; 2014; 18(3):208. PubMed ID: 25306767
    [No Abstract]   [Full Text] [Related]  

  • 62. Development of the antimicrobial effectiveness test as USP chapter <51>.
    Sutton SV; Porter D
    PDA J Pharm Sci Technol; 2002; 56(6):300-11. PubMed ID: 12497767
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Pharmacists emerge as key stakeholders in quality, patient safety efforts.
    Kelly CY; Clancy CM
    J Am Pharm Assoc (2003); 2009; 49(2):146, 150. PubMed ID: 19289338
    [No Abstract]   [Full Text] [Related]  

  • 64. Implementing United States Pharmacopeia Chapter <1163>. Quality assurance in pharmaceutical compounding, Part 3: Testing.
    Allen LV
    Int J Pharm Compd; 2012; 16(4):322-8. PubMed ID: 23050393
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Why UK pharmacy must adapt to the increasing demands of professionalism in practice.
    Agomo CO
    Int J Pharm Pract; 2012 Oct; 20(5):320-3. PubMed ID: 22953771
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Health care reform and the role of the pharmacist.
    Simenson S; Nau DP; Reed B
    J Am Pharm Assoc (2003); 2009; 49(3):356, 360-2. PubMed ID: 19443316
    [No Abstract]   [Full Text] [Related]  

  • 67. Mapping the route to medication therapy management documentation and billing standardization and interoperabilility within the health care system: meeting proceedings.
    Millonig MK
    J Am Pharm Assoc (2003); 2009; 49(3):372-82. PubMed ID: 19357067
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Practice and attitudes regarding the management of childhood diarrhoea among pharmacies in Thailand.
    Saengcharoen W; Lerkiatbundit S
    Int J Pharm Pract; 2010 Dec; 18(6):323-31. PubMed ID: 21054592
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Measuring pharmacy performance in the area of medication adherence: addressing the issue of risk adjustment.
    Dharmarajan S; Bentley JP; Banahan Iii BF; West-Strum DS
    J Manag Care Spec Pharm; 2014 Oct; 20(10):1057-68. PubMed ID: 25278328
    [TBL] [Abstract][Full Text] [Related]  

  • 70. ASHP guideline: minimum standard for pharmaceutical services in ambulatory care. American Society of Health-System Pharmacists.
    Am J Health Syst Pharm; 1999 Sep; 56(17):1744-53. PubMed ID: 10512507
    [No Abstract]   [Full Text] [Related]  

  • 71. Perceptions of current and potential public health involvement of pharmacists in developing nations: The case of Zimbabwe.
    Mdege ND; Chevo T; Toner P
    Res Social Adm Pharm; 2016; 12(6):876-884. PubMed ID: 26703215
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Pharmacy compounding of high-risk level products and patient safety.
    Mullarkey T
    Am J Health Syst Pharm; 2009 Sep; 66(17 Suppl 5):S4-13. PubMed ID: 19710449
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Quality control analytical methods: strategies to ensure a robust quality-control microbiology program.
    Griffiths T; Connors A
    Int J Pharm Compd; 2013; 17(2):130-4. PubMed ID: 23696174
    [TBL] [Abstract][Full Text] [Related]  

  • 74. No ordinary time.
    Woods TM
    Am J Health Syst Pharm; 2007 Apr; 64(8):859-62. PubMed ID: 17420204
    [No Abstract]   [Full Text] [Related]  

  • 75. Revisions continue on USP sterile-compounding chapter.
    Thompson CA
    Am J Health Syst Pharm; 2005 Sep; 62(18):1856, 1858, 1861-2. PubMed ID: 16141100
    [No Abstract]   [Full Text] [Related]  

  • 76. GMPs vs GCPs: manufacturing and compounding definitions.
    Allen LV
    Int J Pharm Compd; 2013; 17(5):356. PubMed ID: 24459778
    [No Abstract]   [Full Text] [Related]  

  • 77. CPD and revalidation: our future is happening now.
    Austin Z
    Res Social Adm Pharm; 2013; 9(2):138-41. PubMed ID: 23062784
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Impact of United States Pharmacopeia chapter 797: results of a national survey.
    Candy TA; Schneider PJ; Pedersen CA
    Am J Health Syst Pharm; 2006 Jul; 63(14):1336-43. PubMed ID: 16809754
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Medicare part D: good for patients and an opportunity for pharmacists.
    Benner JS; Kocot SL
    J Manag Care Pharm; 2009; 15(1):66-70. PubMed ID: 19125552
    [No Abstract]   [Full Text] [Related]  

  • 80. Certification, Accreditation, and Credentialing for 503A Compounding Pharmacies.
    Pritchett J; McCrory G; Kraemer C; Jensen B; Allen LV
    Int J Pharm Compd; 2018; 22(1):7-16. PubMed ID: 29385381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.